Windlas Biotech Limited share

Windlas Biotech Limited

Live Windlas Biotech Limited Share Price Chart

Windlas Biotech Limited Share Performance

Today's Low Today's High
760.00 764.00
849.90 839.75
52 Week Low 52 Week High
474.10 (13-Mar-2024) 475.10 (13-Mar-2024)
1,198.25 (06-Nov-2024) 1,197.00 (06-Nov-2024)

Open
846.00 833.40
Previous Close
835.10 835.90
Volume
0.97
Total Traded value
7.63 (Lakhs)
Upper circuit
1,002.10 577.85
Lower circuit
668.10 385.25

Windlas Biotech Limited Share Market Depth

Buy Order Quantity Sell Order Quantity
65
0

Bid PriceQuantity
768.9065.00
0.000.00
0.000.00
0.000.00
0.000.00
Total:65
Ask PriceQuantity
0.000.00
0.000.00
0.000.00
0.000.00
0.000.00
Total:--

Windlas Biotech Limited Share Fundamentals

Market Cap: 16.45 Cr
PE Ratio (TTM): 26.91
PB Ratio: 3.50
Industry P/E:28.37
Debt to Equity:-
ROE:13.00
EPS (TTM):29.34
Book Value:197.17
Face Value: 5.00

Windlas Biotech Limited Stock Financials

Sep, 2023Jun, 2023Mar, 2023Dec, 2022Sep, 2022
Revenue152.67 Cr144.79 Cr140.71 Cr119.70 Cr132.73 Cr
Profit14.03 Cr12.07 Cr11.45 Cr9.19 Cr12.21 Cr
Expense137.60 Cr131.07 Cr128.00 Cr109.05 Cr119.69 Cr
Comprehensive income14.06 Cr11.74 Cr11.38 Cr9.24 Cr12.23 Cr
EPS6.755.795.374.245.60
Windlas Biotech Limited functions as a Contract Development and Manufacturing Organization (CDMO), providing a range of services such as product discovery, development, licensing, and commercial manufacturing of generic products. The company delivers its CDMO products and services for pharmaceutical and nutraceutical conventional and novel products, allowing customers to market these products under their own brand names. In addition, Windlas Biotech manufactures domestic trade generics and over-the-counter brand products, catering to markets related to nutrition, ayurvedic solutions, wellness, and personal care. The distribution of its domestic trade generics and OTC brands involves both offline channels, including distributors, stockists, retail pharmacies, and institutional tenders, as well as online channels through various e-commerce platforms. The company exports its products to countries such as Vietnam, Myanmar, Sri Lanka, Thailand, the Philippines, Cambodia, Fiji, Trinidad & Tobago, and South Africa. Established in 2001, Windlas Biotech Limited is headquartered in Gurugram, India.
Company nameListing dateIndustry NSE symbol BSE symbol
Windlas Biotech Limited Aug, 2021 Aug, 2021 Pharmaceuticals Pharmaceuticals WINDLAS WINDLAS

Windlas Biotech Limited Stock Shareholding pattern

Sep, 2023 Jun, 2023 Apr, 2023 Mar, 2023 Feb, 2023

  • Promoters 
    62.82%
    Public 
    37.18%
    Shares held by Employee Trusts 
    0.00%
  • Promoters 
    62.82%
    Public 
    37.18%
    Shares held by Employee Trusts 
    0.00%
  • Promoters 
    62.44%
    Public 
    37.56%
    Shares held by Employee Trusts 
    0.00%
  • Promoters 
    62.38%
    Public 
    37.62%
    Shares held by Employee Trusts 
    0.00%
  • Promoters 
    61.22%
    Public 
    38.78%
    Shares held by Employee Trusts 
    0.00%

Windlas Biotech Limited Share FAQ's

What is the range of today's stock performance for Windlas Biotech Limited?

Today's stock performance witnessed a fluctuation from a minimum of 760.00 on the NSE (National Stock Exchange) to a maximum of 849.90. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 764.00 to a high of 839.75.

What are the 52-week low and high values for Windlas Biotech Limited?

The stock's performance over the past 52 weeks reveals a low of 474.10 (occurred on 13-Mar-2024) and a high of 1,198.25 (achieved on 06-Nov-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 475.10 (on 13-Mar-2024), and the 52-week high is 1,197.00 (on 06-Nov-2024).

What was the opening and previous closing prices for Windlas Biotech Limited?

The stock's performance over the past 52 weeks reveals a low of 474.10 (occurred on 13-Mar-2024) and a high of 1,198.25 (achieved on 06-Nov-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 475.10 (on 13-Mar-2024), and the 52-week high is 1,197.00 (on 06-Nov-2024).

What is the total volume and traded value for Windlas Biotech Limited for the day?

The total volume is 1, and the total traded value is 7.63 ( Lakhs).

What are the upper and lower circuit limits for Windlas Biotech Limited?

The upper circuit limit is 1,002.10, and the lower circuit limit is 668.10.

What is the market cap and PE ratio for Windlas Biotech Limited?

The market cap is 16.45 Cr, and the PE ratio (TTM) is 28.37.

What is the PB ratio, industry P/E, and debt to equity ratio for Windlas Biotech Limited?

The PB ratio is 3.98, industry P/E is 28.37 .

What are the financial metrics such as ROE, EPS, dividend yield, book value, and face value for Windlas Biotech Limited?

ROE is 13.00, EPS is 29.34, book value is 197.17

What are the revenue and profit figures for the latest quarter and previous quarters for Windlas Biotech Limited?

In Sep 2023, Revenue is 1526720000.00, and Profit is 140310000.00. In Jun 2023, Revenue is 1447860000.00, and Profit is 120660000.00.

When was Windlas Biotech Limited listed, and what industry does it belong to?

The company, Windlas Biotech Limited, was listed in Aug 2021 and belongs to the Pharmaceuticals industry. Its NSE symbol is WINDLAS.

What is the current shareholding pattern of the Windlas Biotech Limited?

As of latest available update, promoters hold 62.82%, the public holds 37.18%, and Employee Trusts holds 0.00.

The Indian Community

Public Community

Discover the vibrant tapestry of 'The Indian Community' - a melting pot of diverse cultures, traditions, and values. Explore its rich heritage, festivals, and contributions, as this online hub celebrates the essence of India's people, connecting, inspiring, and fostering unity worldwide.

Members
39
online
121
Threads
242
Settings
Back
Top